Prognostic Factors and Long-Term Survival in Locally Advanced NSCLC with Pathological Complete Response after Surgical Resection Following Neoadjuvant Therapy
<i>Background:</i> Outcomes for locally advanced NSCLC with pathological complete response (pCR), i.e., pT0N0 after induction chemoradiotherapy (IT), have been seldom investigated. Herein, long-term results, in this highly selected group of patients, have been evaluated with the aim to i...
Main Authors: | Filippo Lococo, Carolina Sassorossi, Dania Nachira, Marco Chiappetta, Leonardo Petracca Ciavarella, Emanuele Vita, Luca Boldrini, Jessica Evangelista, Alfredo Cesario, Emilio Bria, Stefano Margaritora |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3572 |
Similar Items
-
Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant Therapy
by: Marco Chiappetta, et al.
Published: (2021-03-01) -
Diagnostic Performance of PET or PET/CT with Different Radiotracers in Patients with Suspicious Lung Cancer or Pleural Tumours according to Published Meta-Analyses
by: Filippo Lococo, et al.
Published: (2020-01-01) -
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?
by: Eric D. Brooks, et al.
Published: (2019-06-01) -
Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
by: Yi C, et al.
Published: (2019-09-01) -
Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial
by: Florian Eichhorn, et al.
Published: (2019-05-01)